“ Treatment With Dasatinib or Nilotinib in Chronic Myeloid Leukemia Patients Who Failed to Respond to Two Previously Administered Tyrosine Kinase Inhibitors - a Single Center Experience ”. Clinics, vol. 70, no. 8, Aug. 2015, pp. 550-5, https://doi.org/10.6061/clinics/2015(08)04.